|
|
|
Volumn 23, Issue 3, 1996, Pages 369-378
|
|
Adjuvant therapy of gastric cancer: The Japanese experience
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTARABINE;
FLUOROURACIL;
KRESTIN;
MITOMYCIN C;
PICIBANIL;
TEGAFUR;
URACIL DERIVATIVE;
ADJUVANT THERAPY;
ADULT;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISSECTION;
HUMAN;
IMMUNOTHERAPY;
PERIOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROBABILITY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STOMACH CANCER;
SURVIVAL RATE;
TREATMENT PLANNING;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL RESPONSE MODIFIERS;
CARCINOMA;
CHEMOTHERAPY, ADJUVANT;
GASTRECTOMY;
HUMANS;
IMMUNOTHERAPY;
JAPAN;
LYMPH NODE EXCISION;
NEOPLASM STAGING;
NEOPLASM, RESIDUAL;
PICIBANIL;
PROTEOGLYCANS;
RANDOMIZED CONTROLLED TRIALS;
STOMACH NEOPLASMS;
SURVIVAL RATE;
|
|
EID: 0029938511
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (30)
|
|
References (0)
|
